The first three items on your timeline were all announced to the market within 11 days of each other. If you were to assume each agreement has the same interim reporting KPIs it would imply the following:
Announced Interim Results Final Results (indicative 12 months) 1 Preclinical Melanoma 19 March 2021 30 September 2021 19 March 2022 2 Preclinical ccRCC 25 March 2021 6 October 2021** 25 March 2022** 3 Preclinical EM AML 30 March 2021 11 October 2021** 30 March 2022**
The activities under each agreement will obviously differ but I imagine the reporting requirements don't.
Industry news, page-161
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
0.000(0.00%) |
Mkt cap ! $281.1M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.66 | $1.61 | $117.0K | 71.51K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12252 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 900 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |